Compare Ginkgo Bioworks Holdings Inc (DNA) vs H2O America (HTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs H2O America — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while H2O America trades at $58.48 (market cap $2.43B). The key difference: H2O America is far larger — about 3.2× Ginkgo Bioworks Holdings Inc's market cap, and H2O America pays a 3.03% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and H2O America for 40 Days on average.
| DNA | HTO | |
|---|---|---|
Market Cap | $763.64M | $2.43B |
Volume | 3,204,177 | 593,883 |
Sector | Health | Utilities |
52-Week High | $15.83 | $65.43 |
52-Week Low | $5.48 | $44.44 |
Typical Hold Time | 7 Days | 40 Days |
Enterprise Value | $865.59M | $4.22B |
Dividend Yield | — | 3.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day. The technical outlook is bullish based on moving averages, while oscillators are neutral. Fundamentally, the company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with a negative net income margin of -219.6%. Recent news includes a partnership with TuneLab and a $17.5 million ARPA-H subcontract.
The outlook is challenged by persistent losses and negative cash flow, though strategic partnerships offer growth potential. Analyst sentiment is divided evenly between buy, hold, and sell ratings. Key risks include execution on profitability and high cash burn. The stock presents a speculative opportunity dependent on the company's ability to monetize its technology platform.
HTO trades at $58.07, up 0.16% with a bearish technical signal despite bullish oscillators. The company shows solid fundamentals with 12.91% net income margin and recent earnings beats in Q1 and Q2 2026. Analyst consensus is strongly bullish with 83% buy ratings and a $66.50 price target. Recent acquisitions in Texas water utilities demonstrate strategic growth, though cash flow trends show heavy investment activity.
The stock presents a compelling value opportunity with reasonable valuation multiples and strong institutional interest. Key risks include execution challenges from recent acquisitions and potential EPS dilution. With positive earnings momentum and strategic expansion, HTO offers growth potential but requires monitoring of integration success and cash flow management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About H2O America
H2O America is a utility company that provides essential water and wastewater services, primarily in the United States. The company operates a network of regulated water and wastewater systems, focusing on responsible resource management and high-quality service delivery. HTO aims to expand its operational footprint through acquisitions and internal growth, serving residential, commercial, and industrial customers.
Read more on HTO →
